Neoadjuvant chemotherapy with Cisplatin in BRCA1 mutation carriers – results of treatment

by Byrski T, Gronwald J, Huzarski T, Marczyk E, Blecharz P, Ashuryk O, Cybulski C, Zuziak D, Wiśniowski R, Godlewski D, Narod SA, Lubiński J
Published 2012-04-01

CHEK2 mutations as markers for high risk of breast cancer

by Cybulski Cezary, Wokołorczyk Dominika, Jakubowska Anna, Huzarski Tomasz, Byrski Tomasz, Gronwald Jacek, Dębniak Tadeusz, Górski Bohdan, Blecharz P, Narod S A, Lubiński Jan
Published 2012-04-01

Why choose the treatment with cisplatin for BRCA1 breast cancers patients?

by Byrski T, Huzarski T, Marczyk E, Blecharz P, Gronwald J, Ashuryk O, Cybulski C, Dębniak T, Zuziak D, Godlewski D, Kladny J, Lubinski J, Narod SA
Published 2012-01-01

Neoadjuvant therapy with cisplatin in BRCA1-positive breast cancer patients

by Byrski T, Gronwald J, Huzarski T, Dent RA, Zuziak D, Wiśniowski R, Marczyk E, Blecharz P, Szurek O, Cybulski C, Dębniak T, Górski B, Lubiński J, Narod S
Published 2011-06-01